Moolec Science SA - Warrants (30/12/2027) EBIT

The latest EBIT for MLECW is $-6.4M as of December 2024. That compares with $-7.4M in the prior-year period — up 13.5% year over year. That is above the sector sector average of $-77M. Investors often review this figure alongside Moolec Science SA - Warrants (30/12/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MLECW's EBIT moved from $-7.4M to $-6.4M — a 13.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Moolec Science SA - Warrants (30/12/2027)'s operating scale or balance-sheet position.

Against its sector companies, MLECW currently prints $-6.4M for EBIT, while the sector average sits near $-77M. That is roughly 91.6% above the sector mean. Large gaps often invite a closer look at Moolec Science SA - Warrants (30/12/2027)'s growth, margins, and balance sheet.

A EBIT figure of $-6.4M for MLECW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting MLECW's EBIT ($-6.4M), review year-over-year change from $-7.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.